Invivyd (IVVD) Receivables - Other (2021 - 2025)
Invivyd (IVVD) posted Receivables - Other of $676000.0 for Q4 2025, up 139.72% on a QoQ basis from $282000.0 in Q3 2025, and up 157.03% year-over-year from $263000.0 in Q4 2024.
Invivyd (IVVD) Receivables - Other (2021 - 2025) Analysis & Trends
Invivyd's Receivables - Other history runs 5 years deep, the most recent figure standing at $676000.0 for Q4 2025.
- Quarterly Receivables - Other rose 157.03% year-over-year to $676000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $676000.0 (up 157.03% YoY) and the FY2025 annual result came in at $676000.0, up 157.03% from the prior year.
- Receivables - Other was $676000.0 for Q4 2025 at Invivyd, up from $282000.0 in the prior quarter.
- Across five years, Receivables - Other topped out at $933000.0 in Q4 2023 and bottomed at $111000.0 in Q2 2025.
- A 5-year average of $502800.0 and a median of $474000.0 in 2023 frame the typical range for Receivables - Other.
- Peak annual rise in Receivables - Other reached 157.03% in 2025, while the deepest fall reached 82.63% in 2025.
- Invivyd's Receivables - Other stood at $229000.0 in 2021, then jumped by 64.63% to $377000.0 in 2022, then surged by 147.48% to $933000.0 in 2023, then sank by 71.81% to $263000.0 in 2024, then soared by 157.03% to $676000.0 in 2025.
- Business Quant data shows IVVD's Receivables - Other at $676000.0 in Q4 2025, $282000.0 in Q3 2025, and $111000.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - |
| 10 | Invivyd | 104.07 Mn | -122.62 Mn | 16.07 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 676,000.00 |
| Dec 31, 2025 | 676,000.00 |
| Sep 30, 2025 | 282,000.00 |
| Sep 30, 2025 | 282,000.00 |
| Jun 30, 2025 | 111,000.00 |
| Jun 30, 2025 | 111,000.00 |
| Mar 31, 2025 | 192,000.00 |
| Mar 31, 2025 | 192,000.00 |
| Dec 31, 2024 | 263,000.00 |
| Dec 31, 2024 | 263,000.00 |
| Sep 30, 2024 | 460,000.00 |
| Sep 30, 2024 | 460,000.00 |
| Jun 30, 2024 | 639,000.00 |
| Jun 30, 2024 | 639,000.00 |
| Mar 31, 2024 | 875,000.00 |
| Mar 31, 2024 | 875,000.00 |
| Dec 31, 2023 | 933,000.00 |
| Dec 31, 2023 | 933,000.00 |
| Sep 30, 2023 | 713,000.00 |
| Sep 30, 2023 | 713,000.00 |